• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Natera, Inc. - Common Stock (NQ:NTRA)

    233.13 -21.27 (-8.36%)
    Streaming Delayed Price Updated: 2:55 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,365,240
    Open 252.48
    Bid (Size) 232.77 (100)
    Ask (Size) 233.47 (600)
    Prev. Close 254.40
    Today's Range 232.29 - 256.00
    52wk Range 125.38 - 256.36
    Shares Outstanding 137,533,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer
    From Exelixis, Inc.
    Via Business Wire

    Performance

    YTD
    +1.9%
    +1.9%
    1 Month
    -2.5%
    -2.5%
    3 Month
    +35.5%
    +35.5%
    6 Month
    +44.1%
    +44.1%
    1 Year
    +36.8%
    +36.8%

    More News

    Read More
    News headline image
    Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology
    From Natera, Inc.
    Via Business Wire
    News headline image
    The Year-End Biotech Chill: Adaptive Biotechnologies Braces for J.P. Morgan Crucible Amid Market Sell-Off
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    3 Growth Stocks with Explosive Upside
    Via StockStory
    Topics Energy
    News headline image
    3 Reasons We’re Fans of Natera (NTRA)
    Via StockStory
    Topics Stocks
    News headline image
    3 Market-Beating Stocks Worth Your Attention
    Via StockStory
    News headline image
    Natera to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    I-SPY 2 Publication in Nature Communications Shows Signatera™ Can Predict Treatment Response and Recurrence Risk in Early-Stage Breast Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post‑Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2‑ Breast Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera Acquires Foresight Diagnostics
    From Natera, Inc.
    Via Business Wire
    News headline image
    New Signatera™ Data in Lymphoma and Multiple Myeloma to be Presented at the 2025 American Society of Hematology Annual Meeting
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium
    From Natera, Inc.
    Via Business Wire
    News headline image
    3 Cash-Producing Stocks with Solid Fundamentals
    Via StockStory
    News headline image
    30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Economy Government
    News headline image
    Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Natera, Amneal, Chemed, The Pennant Group, and HCA Healthcare Shares Are Soaring, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Spotting Winners: Natera (NASDAQ:NTRA) And Immuno-Oncology Stocks In Q3
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Employees Volunteer Over 1,500 Hours During Natera’s Annual Volunteer Month
    From Natera, Inc.
    Via Business Wire
    News headline image
    Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗
    Via Benzinga

    Frequently Asked Questions

    Is Natera, Inc. - Common Stock publicly traded?
    Yes, Natera, Inc. - Common Stock is publicly traded.
    What exchange does Natera, Inc. - Common Stock trade on?
    Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Natera, Inc. - Common Stock?
    The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
    What is the current price of Natera, Inc. - Common Stock?
    The current price of Natera, Inc. - Common Stock is 233.13
    When was Natera, Inc. - Common Stock last traded?
    The last trade of Natera, Inc. - Common Stock was at 01/08/26 02:55 PM ET
    What is the market capitalization of Natera, Inc. - Common Stock?
    The market capitalization of Natera, Inc. - Common Stock is 32.06B
    How many shares of Natera, Inc. - Common Stock are outstanding?
    Natera, Inc. - Common Stock has 32B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.